A multi-centre, randomized, double-blind, double-dummy, multiple-dose, crossover study to evaluate the pharmacodynamics, pharmacokinetics, safety and tolerability of orally inhaled indacaterol administered as either PulmoSphere or lactose-blend powder via the Concept1 device in adult patients with persistent asthma.
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2015
At a glance
- Drugs Indacaterol (Primary) ; Indacaterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 23 Jun 2012 Actual end date (22 May 2012) added as reported by European Clinical Trials Database record.
- 23 Jun 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 01 Dec 2011 Planned number of patients added as 36.